Novel Live Biotherapeutics that Harness the
Gut-Brain Axis

Bloom Science is a clinical-stage biotechnology company on a mission to bring transformative live biotherapeutics to underserved patients with rare or complex neurological diseases and conditions who have not responded to existing therapies.

We are a team of passionate and committed scientists, data-geeks and entrepreneurs inspired to be a catalyst for change in the standard of care by discovering and developing new therapeutics that provide healing and a better quality of life to patients and their families with unmet needs.

Who We Are

How We Do It

Interactions between gut bacteria and the human host are as critical as genetics and a driving factor for many diseases with poorly understood etiology.

Bloom is taking a fundamentally different path to developing medicines by harnessing our expanding insight into how the gut microbiome modulates key processes in the immune system, nervous system and brain.

We investigate how changes in the gut microbiome influence brain biochemistry and immune system activity to develop multi-functional therapeutics addressing multi-pathway driven neurological disorders.



Leaps by Bayer

Leaps by Bayer invests in paradigm-shifting advances in the life sciences – breakthroughs that could change the world for the better.

ALS Investment Fund

A Venture Capital fund that invests in biotech companies developing drugs in a specialized area of disease: neurodegeneration, with a particular focus in ALS.

Apollo Health Ventures

Apollo Health Ventures develops interventions with the potential to prevent or reverse age-related diseases and extend healthy human lifespan.

Social Starts

Social Starts is a venture capital partnership with a unique data-driven approach to investing in moment-of-inception and Series A financing rounds.


At Bloom, we are seeking innovative, passionate, and motivated team members. We are a team of microbiologists, synthetic biologists, computational biologists, and business executives. Our ideas are developed into breakthrough science.